Insider · CIK 0001731933
Matthew Chiodo
Files at GNTX (GENTEX CORP). First filing Feb 19, 2026, latest Feb 19, 2026.
In brief
Matthew Chiodo files SEC Form 4 as officer at GNTX (GENTEX CORP). Since Feb 19, 2026, Matthew Chiodo has reported 0 open-market buys worth $0 and 1 open-market sell worth $496k, the latest filed on Feb 19, 2026.
A track record needs three past buys with six months of prices behind them; Matthew Chiodo has 0, so none is measured yet.
The newest scored trade: sold $496k of GNTX on Feb 17, 2026, filed Feb 19, 2026, scored 58 (moderate). In the last 12 months: 0 buys worth $0 and 1 sell worth $496k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
GNTX: GENTEX CORP
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 58Moderate | GENTEX CORP | $496k 19,827 shares | -36% | +21% from low-15% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Feb 17, 2026 | GNTX GENTEX CORPORATION | 19,827 0.01% of outstanding | $496k | Feb 17, 2026 | none |
Transactions
Every row this insider has filed, 10 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 17, 2026 | GNTX GENTEX CORP | AGrant or award Common Stock | +28,269 | $0.00 | $0 | 70,679 | Feb 19, 2026 |
| Feb 17, 2026 | GNTX GENTEX CORP | FTax withholding Common Stock | -12,564 | $24.89 | $313k | 58,115 | Feb 19, 2026 |
| Feb 17, 2026 | GNTX GENTEX CORP | FTax withholding Common Stock | -3,187 | $24.89 | $79k | 54,928 | Feb 19, 2026 |
| Feb 17, 2026 | GNTX GENTEX CORP | SOpen-market sale Common Stock | -15,705 | $25.03 | $393k | 39,223 | Feb 19, 2026 |
| Feb 17, 2026 | GNTX GENTEX CORP | SOpen-market sale Common Stock | -4,122 | $25.03 | $103k | 35,101 | Feb 19, 2026 |
| Feb 19, 2026 | GNTX GENTEX CORP | AGrant or award Common Stock | +12,047 | $0.00 | $0 | 47,148 | Feb 19, 2026 |
| Feb 20, 2025 | GNTX GENTEX CORP | AGrant or award Common Stock | +9,130 | $0.00 | $0 | 41,342 | Feb 21, 2025 |
| Feb 18, 2025 | GNTX GENTEX CORP | AGrant or award Common Stock | +11,433 | $0.00 | $0 | 43,889 | Feb 19, 2025 |
| Feb 18, 2025 | GNTX GENTEX CORP | FTax withholding Common Stock | -5,539 | $24.62 | $136k | 38,350 | Feb 19, 2025 |
| Feb 18, 2025 | GNTX GENTEX CORP | FTax withholding Common Stock | -6,138 | $24.62 | $151k | 32,212 | Feb 19, 2025 |
Questions about Matthew Chiodo
Answered from the filings on this page, as of the latest one.
Is Matthew Chiodo buying or selling?
In the last 12 months Matthew Chiodo reported 0 open-market buys worth $0 and 1 open-market sell worth $496k on SEC Form 4; the latest was sold $496k of GNTX on Feb 17, 2026. Grants, option exercises and tax withholding are not counted.
How did Matthew Chiodo's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Matthew Chiodo has 0.
Where does Matthew Chiodo file Form 4?
Matthew Chiodo has filed Form 4 at GNTX (GENTEX CORP) as Vice President of Sales. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.